Home|Best-Bschool-in-india-2018

DSIJ Mindshare

Aurobindo Pharma takes a step forward to cure COVID-19; collaborates with US company COVAXX Aurobindo Pharma takes a step forward to cure COVID-19; collaborates with US company COVAXX

Aurobindo Pharma takes a step forward to cure COVID-19; collaborates with US company COVAXX

Shreya Chaware 0 1428 Article rating: 3.7

On Thursday, Aurobindo Pharma, a leading pharma company, signed an exclusive agreement with COVAXX, a US-based company for developing and commercialising COVID-19 vaccine i.e. UB-612, the first multitope peptide-based vaccine to fight COVID-19, for India and United Nations Children's Fund (UNICEF) agency. 

Read more
Bajaj Auto gets nod from Maharashtra Government for Rs 650 crore investment; signs MoU Bajaj Auto gets nod from Maharashtra Government for Rs 650 crore investment; signs MoU

Bajaj Auto gets nod from Maharashtra Government for Rs 650 crore investment; signs MoU

Shreya Chaware 0 853 Article rating: 5.0

Bajaj Auto Limited informed the bourses on Tuesday after the market hours that it has signed a memorandum of understanding (MoU) with the Government of Maharashtra for setting up a manufacturing facility on a proposed investment of Rs 650 crore in Chakan (Maharashtra). 

Read more
AstraZeneca Pharma opens door for severe & rare asthma treatment; stock slumps 3 per cent AstraZeneca Pharma opens door for severe & rare asthma treatment; stock slumps 3 per cent

AstraZeneca Pharma opens door for severe & rare asthma treatment; stock slumps 3 per cent

Shreya Chaware 0 1179 Article rating: 2.5

AstraZeneca Pharma India Limited informed on Monday that it has been granted permission by Drugs Controller General of India (DCGI) for importing & marketing of Benralizumab 30mg/ml solution for injection (Fasenra™). The medicine helps in treating a severe & rare type of asthma caused mainly in adults. 

Read more
RSS
First150151152153154155157159
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList